1 study found for:    21353695 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-refractory Prostate Cancer
Condition: Bone Metastases
Interventions: Drug: zoledronic acid;   Biological: denosumab

Indicates status has not been verified in more than two years